Barber C, Terplan M
Front Pediatr. 2023; 11:1045745.
PMID: 37292372
PMC: 10246753.
DOI: 10.3389/fped.2023.1045745.
Kelty E, Cumming C, Preen D
Pharmacotherapy. 2022; 42(5):405-410.
PMID: 35342965
PMC: 9541824.
DOI: 10.1002/phar.2678.
Cairncross Z, Herring J, van Ingen T, Smith B, Leece P, Schwartz B
CMAJ Open. 2018; 6(4):E478-E485.
PMID: 30337473
PMC: 6201733.
DOI: 10.9778/cmajo.20180084.
Brandlistuen R, Ystrom E, Hernandez-Diaz S, Skurtveit S, Selmer R, Handal M
PLoS One. 2017; 12(7):e0181042.
PMID: 28746341
PMC: 5528839.
DOI: 10.1371/journal.pone.0181042.
Borgelt L, Hart F, Bainbridge J
Int J Womens Health. 2016; 8:505-517.
PMID: 27703396
PMC: 5036546.
DOI: 10.2147/IJWH.S98973.
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects.
Convertino I, Capogrosso Sansone A, Marino A, Galiulo M, Mantarro S, Antonioli L
Drug Saf. 2016; 39(10):903-24.
PMID: 27289228
DOI: 10.1007/s40264-016-0435-8.
Risk of Hospital Readmission Among Infants With Neonatal Abstinence Syndrome.
Patrick S, Burke J, Biel T, Auger K, Goyal N, Cooper W
Hosp Pediatr. 2015; 5(10):513-9.
PMID: 26427919
PMC: 5110214.
DOI: 10.1542/hpeds.2015-0024.
Prenatal exposure to anxiolytics and hypnotics and language competence at 3 years of age.
Odsbu I, Skurtveit S, Selmer R, Roth C, Hernandez-Diaz S, Handal M
Eur J Clin Pharmacol. 2014; 71(3):283-91.
PMID: 25547568
DOI: 10.1007/s00228-014-1797-4.
The use of central nervous system active drugs during pregnancy.
Kallen B, Borg N, Reis M
Pharmaceuticals (Basel). 2013; 6(10):1221-86.
PMID: 24275849
PMC: 3817603.
DOI: 10.3390/ph6101221.
[Not Available].
Menard C
Can Fam Physician. 2011; 25:721-3.
PMID: 21297708
PMC: 2382991.
Teratogenic Effects of `Recreational' Drugs: Increasing the risk of congenital anomalies.
Polifka J, Friedman J
Can Fam Physician. 2011; 37:1953-62.
PMID: 21229112
PMC: 2145913.
Medications for panic disorder and generalized anxiety disorder during pregnancy.
Rubinchik S, Kablinger A, Gardner J
Prim Care Companion J Clin Psychiatry. 2005; 7(3):100-5.
PMID: 16027764
PMC: 1163270.
DOI: 10.4088/pcc.v07n0304.
Diazepam withdrawal syndrome: its prolonged and changing nature.
Mellor C, Jain V
Can Med Assoc J. 1982; 127(11):1093-6.
PMID: 7139456
PMC: 1862031.
The effect of prenatal exposure to diazepam on aspects of postnatal development and behavior in rats.
Gai N, Grimm V
Psychopharmacology (Berl). 1982; 78(3):225-9.
PMID: 6818579
DOI: 10.1007/BF00428155.
Decreased serum protein binding of diazepam and its major metabolite in the neonate during the first postnatal week relate to increased free fatty acid levels.
Nau H, Luck W, Kuhnz W
Br J Clin Pharmacol. 1984; 17(1):92-8.
PMID: 6419763
PMC: 1463308.
DOI: 10.1111/j.1365-2125.1984.tb05006.x.
Adverse effects of antianxiety drugs.
Edwards J
Drugs. 1981; 22(6):495-514.
PMID: 6119192
DOI: 10.2165/00003495-198122060-00005.
Benzodiazepines: clinical pharmacology and therapeutic use.
Bellantuono C, Reggi V, Tognoni G, Garattini S
Drugs. 1980; 19(3):195-219.
PMID: 6102508
DOI: 10.2165/00003495-198019030-00004.
Psychotropic drugs.
LOUDON J
Br Med J (Clin Res Ed). 1987; 294(6565):167-9.
PMID: 2885059
PMC: 1245170.
DOI: 10.1136/bmj.294.6565.167.
Psychotropic medication use during pregnancy.
Guze B, Guze P
West J Med. 1989; 151(3):296-8.
PMID: 2686167
PMC: 1026861.
Benzodiazepine poisoning. Clinical and pharmacological considerations and treatment.
Gaudreault P, Guay J, Thivierge R, Verdy I
Drug Saf. 1991; 6(4):247-65.
PMID: 1888441
DOI: 10.2165/00002018-199106040-00003.